Biopharmaceutics classification system: A regulatory approach

Dissolution Technologies

Volumn 18, Issue 1, 2011, Pages 31-37

  Basanta Kumar Reddy, B ^a   Karunakar, A ^b  

^a Maharashtra Industrial Development Corporation India   (India)

^b DR REDDY'S LABORATORIES LTD   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOEQUIVALENCE; DISSOLUTION; DRUG ABSORPTION; DRUG PENETRATION; DRUG SOLUBILITY; HUMAN; IN VITRO STUDY; MATHEMATICAL ANALYSIS; PERMEABILITY; PHARMACODYNAMICS;

EID: 79953020158     PISSN: 1521298X     EISSN: None     Source Type: Journal    
DOI: 10.14227/dt180111p31     Document Type: Article

References (17)

1. Rinaki, E.; Valsami, G.; Macheras, P. Quantitative biopharmaceutics classification system: The central role of dose/solubility ratio. Pharm. Res. 2003, 20 (12), 1917-1925.
2. Waiver of In Vivo Bioavailability and Bioequivalence Studies for Immediate-Release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification System; Guidance for Industry; U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), U.S. Government Printing Office: Washington, DC, August 2000. http://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/ Guidances/ucm070246.pdf (accessed Jan 11, 2011).
3. Yu, L. X.; Amidon, G. L.; Polli, J. E.; Zhao, H.; Mehta, M. U.; Conner, D. P.; Shah, V. P.; Lesko, L. J.; Chen, M. L.; Lee, V. H. L. Biopharmaceutics classification system: The scientific basis for biowaiver extensions. Pharm. Res. 2002, 19 (7), 921-925.
4. Lindenberg, M.; Kopp, S.; Dressman, J. B. Classification of orally administered drugs on the World Health Organization model list of essential medicines according to the biopharmaceutics classification system. Eur. J. Pharm. Biopharm. 2004, 58, 265-278.
5. Varma, M. V.; Khandavilli, S.; Ashokraj, Y.; Dhanikula, A.; Sood, A.; Thomas, N. S.; Pillai, O.; Sharma, P.; Gandhi, R.; Agrawal, S.; Nair, V.; Panchagnula, R. Biopharmaceutic classification system: A scientific framework for pharmacokinetic optimization in drug research. Curr. Drug Metab. 2004, 5 (5), 375-388.
6. Amidon, G. L.; Lennernas, H.; Shah, V. P.; Crison, J. R. A. A theoretical basis for a biopharmaceutic drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res. 1995, 12 (3), 413-419.
7. Gothoskar, A. V. Biopharmaceutical classification of drugs. Pharm. Rev. [Online] 2005, 3 (1). http://www.pharmainfo.net/reviews/biopharmaceutical-classification-drugs (accessed Jan 18, 2011).
8. Hussain, A. S.; Lesko, L. J.; Lo, K. Y.; Shah, V. P.; Volpe, D.; Williams, R. L. The Biopharmaceutics Classification System: Highlights of the FDA's Draft Guidance. Dissolution Technol. 1999, 6 (2), 5-9. http://www.dissolutiontech.com/DTresour/599articles/Biopharm_Class2_copy.html (accessed Jan 18, 2011).
9. Devane, J. Oral drug delivery technology: Addressing the solubility/permeability paradigm. Pharm. Technol. 1998, 22, 68-74.
10. Lipka, E.; Amidon, G. L. Setting bioequivalence requirements for drug development based on preclinical data: Optimizing oral drug delivery systems. J. Controlled Release. 1999, 62, 41-49.
11. Polli, J. E.; Yu, L. X.; Cook, J. A.; Amidon, G. L.; Borchardt, R. T.; Burnside, B. A.; Burton, P. S.; Chen, M. L.; Conner, D. P.; Faustino, P. J.; Hawin, A.; Hussain, A. S.; Joshi, H. N.; Kwei, G.; Lee, V. H. L.; Lesko, L. J.; Lipper, R. A.; Loper, A. E.; Nerurkar, S. G.; Polli, J. W.; Sanvordeker, D. R.; Taneja, R.; Uppoor, R. S.; Vattikonda, C. S.; Wilding, I.; Zhang, G. Summary workshop report: Biopharmaceutics classification system-implementation challenges and extension opportunities. J. Pharm. Sci. 2004, 93 (6), 1375-1381.
12. Gohel, M. C. An audit of recent inputs on biopharmaceutical classification system. Pharm. Rev. [Online] 2005, 3 (1). http://www.pharmainfo.net/reviews/ audit-recent-inputs-biopharmaceutical-classificationsystem (accessed Jan 18, 2011).
13. United States Pharmacopeia and National Formulary USP 23-NF 18; The United States Pharmacopeial Convention, Inc.: Rockville, MD, 1994.
14. Sacham, N. K.; Bhattacharya, A.; Pushkar, S.; Mishra, A. Biopharmaceutical classification system: A strategic tool for oral drug delivery technology. Asian J. Pharm. 2009, 3 (2), 76-81.
15. Stuart, M.; Box, K. Chasing equilibrium: measuring the intrinsic solubility of weak acids and bases. Anal. Chem. 2005, 77 (4), 983-990.
16. Blume, H. H.; Schug, B. S. The biopharmaceutics classification system (BCS): Class III drugs better candidates for BA/BE waiver? Eur. J. Pharm. Sci. 1999, 9 (2), 117-121.
17. Dressman, J. B.; Reppas, C. In vivo-in vitro correlations for lipophilic, poorly water-soluble drugs. Eur. J. Pharm. Sci. 2000, 11 (Suppl. 2), S73-S80.